Cat. No.: DMM-001290
| Status | Age | Sex |
|---|---|---|
|
|
|
| Model Overview | |
|---|---|
| Model Description | Mice homozygous for the fat spontaneous mutation (Cpefat) become noticeably obese by 14-15 weeks of age. Homozygous mutant mice develop a diabetic phenotype characterized by hyperglycemia and insulin resistance. |
| Strain Name | B6.HRS(BKS)-Cpefat/J |
| Background Strain | C57BL/6J |
| SPF | Yes |
| Research Application | Diabetes |
| Target Information | |
|---|---|
| Target Name | carboxypeptidase E |
| Synonyms | BDVS, CARBE, carboxypeptidase H, Cph, Cph1, Cph-1, IDDHH, NF-alpha1 |
| Gene ID | - |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.